Mostrando 10 resultados de: 16
Filtros aplicados
Subtipo de publicación
Article(16)
Área temáticas
Enfermedades(12)
Medicina y salud(9)
Problemas sociales y servicios a grupos(6)
Salud y seguridad personal(6)
Fisiología humana(5)
Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies
ArticleAbstract: Background Several studies reported a U-shaped association between urinary sodium excretion and cardPalabras claves:Autores:Anand S.S., Avezum A.J., Bahonar A., Chifamba J., Dagenais G.R., DIaz R., Iqbal R., Lanas F., Lear S.A., Li W., Lu Y., Mann J.F.E., McQueen M.J., Mente A., Mony P.K., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rensheng L., Rosengren A., Schutte A.E., Szuba A., Teo K.K., Yi S., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusAlcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: A prospective cohort study
ArticleAbstract: Summary Background Alcohol consumption is proposed to be the third most important modifiable risk faPalabras claves:Autores:Avezum A.J., Chifamba J., Dagenais G.R., DIaz R., Jian B., Kumar R., Lear S.A., Leong D.P., Mckee M., Mohan V., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rana P., Rangarajan S., Rosengren A., Schutte A.E., Seron P., Smyth A., Szuba A., Teo K.K., Wei L., Yang W., Yusuf S., Zhang X.Fuentes:googlescopusFruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
ArticleAbstract: Background The association between intake of fruits, vegetables, and legumes with cardiovascular disPalabras claves:Autores:Agapay D., Altuntas Y., Anand S.S., Auger D., Avezum A.J., Azad A.K., Bangdiwala S.I., Bo H., Bonneville N., Casaccia G., Cayer M., Cherry H.M., Chifamba J., Choudhury T., Chunming C., Corber E., Cuneo J.M., Dagenais G.R., De Bluts A.L.B., de Jong V., Dehghan M., Dejesus J., DIaz R., Elsheikh W., Fodor G.J., Gasevic D., Gupta R., Haque R., Hassan I., Heldman L., Hongye Z., Iqbal R., Jian B., Kay I., Khan M.U., Khatib R., Kutty V.R., Lana F., Lanas F., Lear S.A., Li W., Linetsky B., Liu J., Liu L., Liu X., Mannan A., Marcilio C.S., Martinez S., Mattos A.C., Mente A., Miller V., Mohammadifard N., Mohan V., Noorhassim I., Oliveira G.B.F., Oliveros M.J., Orlandini A., Parvin S., PATRICIO LOPEZ -JARAMILLO, Peer N., Pipe A., Poirier P., Proulx M.C., Rabbani K.A., Rahman O., Ramezani E., Rangarajan S., Rimac J., Rosengren A., Schutte A.E., Seron P., Shane A., Sintaha M., Solano R., Swaminathan S., Talukdar A.T., Teo K.K., Tongana T., Tooheen R.B., Toscanelli S., Trottier S., Turbide G., Valdebenito A., Vukmirovich I., Wei L., Wenhua Z., Wentzel-Viljoen E., Wielgosz A., Xiaohong C., Xingyu W., Xiuwen Z., Xuan J., Yi S., Yin L., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M., Zatońska K., Zhang X.Fuentes:googlescopusGlobal and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
ArticleAbstract: Background Stroke is a leading cause of death and disability, especially in low-income and middle-inPalabras claves:Autores:Agapay S., Al Hussain F., Avezum A.J., Chin S.L., Czlonkowska A., Damasceno A., Dans A.M., Dehghan M., DIaz R., Diener H.C., ElSayed A., Ferguson J., Hankey G.J., Iqbal R., Iversen H.K., Lanas F., Langhorne P., Liu L., Magazi D., Málaga G., McQueen M.J., Mondo C.K., Nilanont Y., Ogah O.S., Ogunniyi A., Oguz A., Oveisgharan S., O’Donnell M., Pais P., Paré G., PATRICIO LOPEZ -JARAMILLO, Peñaherrera E., Pogosova N., Rangarajan S., Rao-Melacini P., Rosengren A., Rumboldt Z., Ryglewicz D., Wang X., Weimar C., Xavier D., Yusoff K., Yusuf S., Yusufali A.M., Zhang H., Zhang X.Fuentes:googlescopusFixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis
ArticleAbstract: Background: In randomised controlled trials, fixed-dose combination treatments (or polypills) have bPalabras claves:Autores:Avezum A.J., Bangdiwala S.I., Bosch J.J., Castellano J.M., Dagenais G.R., Dans A.M., DIaz R., Fuster V., Gamra H., Gao P., Huffman M.D., Joseph P.G., Liu L., Lonn E.M., Malekzadeh R., Pais P., PATRICIO LOPEZ -JARAMILLO, Prabhakaran D., Rodgers A., Roshandel G., Sliwa K., Teo K.K., Xavier D., Yusuf S., Zhu J.Fuentes:googlescopusDulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
ArticleAbstract: Background: Three different glucagon-like peptide-1 (GLP-1) receptor agonists reduce cardiovascularPalabras claves:Autores:Abella M., Alebuena A., Almagro S., Amoroso E., Anadon P., Andreu E., Aristimuño G., Arzadun M., Atisso C.M., Avezum A.J., Barbieri M., Barcudi R., BARTOLACCI I.P., Basile J.N., Bolobanich G., BORDONAVA A.P., Bustamante Labarta M., Bustos B., CACCAVO A., Camino A., Cantero M., Cardona-Munoz E.G., Carignano M., CARTASEGNA L.U.I.S., Chung N., Cipullo M., Colhoun H.M., Commendatore V., Conget I., Conosciuto V., Costamagna O., Crespo C., Cuello J.L., Cuneo C.A., Cushman W.C., Cusimano S., Dagenais G.R., Dean S., DIaz R., Dituro C., Dominguez A., Dyal L., Farah M., Fernandez A., Fernandez F., Ferrari A., Flammia P., Franek E., Fuentealba J., Gallardo K.B., Garcia C., GARCIA DURAN R.O., GARRIDO M., Gavicola R., Gerbaudo C., Gerstein H.C., Gilli G., Giotto A.P., Godoy Bolzán P., Gomez Vilamajo O., Guerlloy F., Guridi C., Gutierrez Garrido N., Hall S., Hâncu N., Hanefeld M., HASBANI E., Hermida S., Holt S., HOMINAL M.A., HRABAR A., Ingaramo A., Izzicupo A., Jansky P., Keltai M., Krynski M., Lagrutta M., Lakshmanan M., Lanas F.T., Lanchiotti P., Langhe M., Leiter L.A., Leonard V., Llanos J., López-Santi R., Pais P., PATRICIO LOPEZ -JARAMILLO, Pirags V., Pogosova N., Probstfield J.L., Rao-Melacini P., Raubenheimer P.J., Riddle M.C., Riesmeyer J.S., Rydén L.E., Shaw J.E., Sheu W.H.H., Temelkova-Kurktschiev T., Washington Stalin García Cuenta, Wong G., Xavier D.Fuentes:googlescopusDulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
ArticleAbstract: Background: Two glucagon-like peptide-1 (GLP-1) receptor agonists reduced renal outcomes in people wPalabras claves:Autores:Abella M., Alebuena A., Almagro S., Amoroso E., Anadon P., Andreu E., Aristimuño G., Arzadun M., Atisso C.M., Avezum A.J., Barbieri M., Barcudi R., BARTOLACCI I.P., Basile J.N., Bolobanich G., BORDONAVA A.P., Botros F.T., Bustamante Labarta M., Bustos B., CACCAVO A., Camino A., Cantero M., Cardona-Munoz E.G., Carignano M., CARTASEGNA L.U.I.S., Chung N., Cipullo M., Colhoun H.M., Commendatore V., Conget I., Conosciuto V., Costamagna O., Crespo C., Cuello J.L., Cuneo C.A., Cushman W.C., Cusimano S., Dagenais G.R., Dean S., DIaz R., Dituro C., Dominguez A., Dyal L., Farah M., Fernandez A., Fernandez F., Ferrari A., Flammia P., Franek E., Fuentealba J., Gallardo K.B., Garcia C., GARCIA DURAN R.O., GARRIDO M., Gavicola R., Gerbaudo C., Gerstein H.C., Gilli G., Giotto A.P., Godoy Bolzán P., Gomez Vilamajo O., Guerlloy F., Guridi C., Gutierrez Garrido N., Hall S., Hâncu N., Hanefeld M., HASBANI E., Hermida S., Holt S., HOMINAL M.A., HRABAR A., Ingaramo A., Izzicupo A., Jansky P., Keltai M., Krynski M., Lagrutta M., Lakshmanan M., Lanas F.T., Lanchiotti P., Langhe M., Leiter L.A., Leonard V., Llanos J., López-Santi R., Pais P., PATRICIO LOPEZ -JARAMILLO, Pirags V., Pogosova N., Probstfield J.L., Rao-Melacini P., Raubenheimer P.J., Riddle M.C., Rydén L.E., Shaw J.E., Sheu W.H.H., Temelkova-Kurktschiev T., Washington Stalin García Cuenta, Wong G., Xavier D.Fuentes:googlescopusMetabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study
ArticleAbstract: Background: There is a paucity of data on the prevalence of risk factors and their associations withPalabras claves:Autores:Abdul-Razak S., Alhabib K.F., Anand S.S., Avezum A.J., Breet Y., Chifamba J., DIaz R., Gupta R., Hu B., Iqbal R., Ismail R., Kelishadi R., Khatib R., Lang X., Li S., Mohan V., Oguz A., Palileo-Villanueva L.M., PATRICIO LOPEZ -JARAMILLO, Pinnaka L.V.M., Poltyn-Zaradna K., R S.P., Rangarajan S., Rosengren A., Seron P., Sharief W.M., Teo K.K., Verghese S.T., Walli-Attaei M., Wielgosz A., Yeates K.E., Yusuf R., Yusuf S.Fuentes:googlescopusModifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
ArticleAbstract: Background: Global estimates of the effect of common modifiable risk factors on cardiovascular diseaPalabras claves:Autores:Alhabib K.F., Avezum A.J., Bo H., Brauer M., Chifamba J., Dagenais G.R., Dans A.M., DIaz R., Gupta R., Hystad P., Iqbal R., Islam S., Joseph P.G., Kaur M., Kelishadi R., Khatib R., Kruger L., Kutty V.R., Lanas F.T., Lear S.A., Leong D.P., Mckee M., Mente A., Mohan V., Mony P.K., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rahman O., Rangarajan S., Rosengren A., Teo K.K., Wei L., Wielgosz A., Yeates K.E., Yusoff K., Yusuf S., Yusufali A.M., Zatońska K.Fuentes:googlescopusUrinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study
ArticleAbstract: Background: WHO recommends that populations consume less than 2 g/day sodium as a preventive measurePalabras claves:Autores:Ah S.T.L., Alhabib K.F., Avezum A.J., Chifamba J., Dagenais G.R., Dans A.M., DIaz R., Gulec S., Iqbal R., Khatib R., Kruger L., Lanas F.T., Lear S.A., McQueen M.J., Mente A., Mohammadifard N., Mony P.K., Noorhassim I., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rosengren A., Szuba A., Teo K.K., Tsolekile L.P., Wei L., Wielgosz A., Yeates K.E., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopus